Afatinib Impurity 19 | CAS 1245555-42-3 - Request Quote
Afatinib Impurity 19
| SZ CAT No: | SZ-A054031 |
| CAS No | 1245555-42-3 |
| Mol.F. | C21H21ClFN5O2 |
| Mol.Wt. | 429.9 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Afatinib Impurity 19 is chemically (E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(dimethylamino)but-2-enamide. Afatinib Impurity 19 is supplied with detailed characterization data compliant with regulatory guideline. Afatinib Impurity 19 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Afatinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1245555-42-3
Purchase 1245555-42-3
Order 1245555-42-3
Enquire 1245555-42-3
price of 1245555-42-3
1245555-42-3 Supplier
1245555-42-3 Manufacturer
1245555-42-3 Exporter
buy high quality Afatinib Impurity 19
Purchase Afatinib Impurity 19
Afatinib Impurity 19 suppliers
Afatinib Impurity 19 manufacturers
Afatinib Impurity 19 price
Order Afatinib Impurity 19
Enquire Afatinib Impurity 19
Afatinib Impurity 19 cost
Afatinib Impurity 19 Supplier
Afatinib Impurity 19 Distributor
Afatinib Impurity 19 for Method Validation
Afatinib Reference Standard
Afatinib Impurity 19 for ANDA Filing
Afatinib Impurity 19 for Forced Degradation Studies
Afatinib Impurity 19 Identification Standards
Afatinib Impurity 19 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.